A RANDOMIZED TRIAL OF ADJUVANT THALIDOMIDE VERSUS OBSERVATION IN PATIENTS WITH COMPLETELY RESECTED HIGH RISK RENAL CELL CARCINOMA

OBJECTIVES: Thalidomide has demonstrated modest activity in patients with metastatic renal cell carcinoma (RCC). We evaluated the role of adjuvant thalidomide after complete resection of high-risk RCC. METHODS: Eligibility criteria for enrollment on this randomized trial included any histological su...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urology
Principais autores: Margulis, Vitaly, Matin, Surena F., Tannir, Nizar, Tamboli, Pheroze, Shen, Yu, Lozano, Marisa, Swanson, David A., Jonasch, Eric, Wood, Christopher G.
Formato: Artigo
Idioma:Inglês
Publicado em: 2008
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4723280/
https://ncbi.nlm.nih.gov/pubmed/18950837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2008.08.476
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados